Oxford Gene Technology

www.ogt.com

Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative genetics research solutions to advance molecular medicine. Our CytoSure, Cytocell and SureSeq range of microarray, FISH and next generation sequencing (NGS) products deliver high-quality, high-throughput genetic analysis, enabling accurate identification of the causative variation underlying genetic disease.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

INSTITUTE FOR BIOSCIENCE AND BIOTECHNOLOGY RESEARCH RECEIVES $16.8 M INVESTMENT FROM THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY

Institute for Bioscience and Biotechnology Research | January 14, 2022

news image

The Institute for Bioscience and Biotechnology Research announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino This award provides more than $3.3 million each year to support groundbreaking research, including technology and standards development that will impact vaccine and therapeutic discovery and development, and to improve access to life-saving treatments...

Read More

PALO ALTO-BASED BIOTECH STARTUP TO MASS MANUFACTURE CLINICAL-GRADE IPSCS FOR CELL THERAPY

I Peace, Inc. | July 16, 2020

news image

I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-size closed cassette. The system was developed in collaboration with FANUC CORPORATION (Head Office: Oshino, Yamanashi Prefecture, Japan; CEO: Kenji Yamaguchi). The technology is modular and scalable with a small foot...

Read More

Medical

ZENFOLD LEVERAGES GINKGO ENZYME SERVICES TO ENABLE VETERINARY ACTIVE INGREDIENT DEVELOPMENT WITH SUSTAINABLE BIOLOGY

PR Newswire | October 17, 2023

news image

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing specialty ingredients using sustainable technologies and precision fermentation, today announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufac...

Read More

Cell and Gene Therapy

VERGE GENOMICS HONORED BY GOLDMAN SACHS FOR ENTREPRENEURSHIP

Verge Genomics | October 17, 2022

news image

Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence and human data to develop new drugs, announced today that Goldman Sachs is recognizing Verge’s Chief Executive Officer and co-founder, Alice Zhang, as one of the Most Exceptional Entrepreneurs of 2022 at its Builders and Innovators Summit in Healdsburg, California. Goldman Sachs selected Zhang from leaders and entrepreneurs across multiple industries. Verge deeply integrates n...

Read More
news image

Research

INSTITUTE FOR BIOSCIENCE AND BIOTECHNOLOGY RESEARCH RECEIVES $16.8 M INVESTMENT FROM THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY

Institute for Bioscience and Biotechnology Research | January 14, 2022

The Institute for Bioscience and Biotechnology Research announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino This award provides more than $3.3 million each year to support groundbreaking research, including technology and standards development that will impact vaccine and therapeutic discovery and development, and to improve access to life-saving treatments...

Read More
news image

PALO ALTO-BASED BIOTECH STARTUP TO MASS MANUFACTURE CLINICAL-GRADE IPSCS FOR CELL THERAPY

I Peace, Inc. | July 16, 2020

I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-size closed cassette. The system was developed in collaboration with FANUC CORPORATION (Head Office: Oshino, Yamanashi Prefecture, Japan; CEO: Kenji Yamaguchi). The technology is modular and scalable with a small foot...

Read More
news image

Medical

ZENFOLD LEVERAGES GINKGO ENZYME SERVICES TO ENABLE VETERINARY ACTIVE INGREDIENT DEVELOPMENT WITH SUSTAINABLE BIOLOGY

PR Newswire | October 17, 2023

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing specialty ingredients using sustainable technologies and precision fermentation, today announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufac...

Read More
news image

Cell and Gene Therapy

VERGE GENOMICS HONORED BY GOLDMAN SACHS FOR ENTREPRENEURSHIP

Verge Genomics | October 17, 2022

Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence and human data to develop new drugs, announced today that Goldman Sachs is recognizing Verge’s Chief Executive Officer and co-founder, Alice Zhang, as one of the Most Exceptional Entrepreneurs of 2022 at its Builders and Innovators Summit in Healdsburg, California. Goldman Sachs selected Zhang from leaders and entrepreneurs across multiple industries. Verge deeply integrates n...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us